| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 28/12/2011 | 01:00 | Zacks | Pharma & Biotech Stock Review & Outlook - Zacks Analyst Interviews | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 27/10/2011 | 21:58 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 07/10/2011 | 19:25 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 06/10/2011 | 18:36 | Edgar (US Regulatory) | Information Statement - All Other (definitive) (DEF 14C) | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 29/09/2011 | 22:44 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 27/09/2011 | 20:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 26/09/2011 | 23:28 | Edgar (US Regulatory) | Proxy Statement - Other Information (preliminary) (PRE 14C) | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 22/09/2011 | 19:00 | Zacks | Pharmaceuticals Stock Outlook - Sept. 2011 - Industry Outlook | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 22/09/2011 | 18:32 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 22/09/2011 | 16:54 | Zacks | Pfizer a Step Closer to Icagen - Analyst Blog | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 20/09/2011 | 14:29 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 20/09/2011 | 14:19 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 20/09/2011 | 14:19 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 20/09/2011 | 14:00 | Business Wire | Pfizer Announces Expiration of Subsequent Offering Period and Completion of Tender Offer for Shares of Icagen, Inc. | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 16/09/2011 | 23:44 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/A) | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 16/09/2011 | 23:23 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 14/09/2011 | 17:00 | Zacks | Pfizer Extends Icagen Offer Again - Analyst Blog | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 13/09/2011 | 14:00 | Business Wire | Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen, Inc. | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 08/09/2011 | 17:47 | Zacks | PFE Tender Offer for Icagen Succeeds - Analyst Blog | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 02/09/2011 | 18:23 | Zacks | Pfizer Extends Icagen Tender Offer - Analyst Blog | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 02/09/2011 | 14:00 | Business Wire | Pfizer Extends Tender Offer To Acquire Icagen, Inc. | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 01/09/2011 | 22:02 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 01/09/2011 | 16:46 | PR Newswire (US) | Merlin Nexus and New Leaf Venture Partners Comment on Extension of Tender Offer Deadline in Conjunction with Pfizer's Propose... | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 01/09/2011 | 14:00 | Business Wire | Pfizer Extends Tender Offer to Acquire Icagen, Inc. | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 29/08/2011 | 14:30 | GlobeNewswire Inc. | Icagen Reaffirms Recommendation to Shareholders to Tender Shares | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 26/08/2011 | 20:03 | Dow Jones News | Pfizer Sticks To $6/Share Offer For Icagen -Reuters | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 26/08/2011 | 19:47 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 25/08/2011 | 14:15 | PR Newswire (US) | Merlin Nexus and New Leaf Venture Partners Continue to Contest Proposed $56 Million Acquisition of Icagen by Pfizer | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 16/08/2011 | 14:30 | GlobeNewswire Inc. | Icagen Reiterates Its Recommendation That Stockholders Accept Pfizer's Offer of $6 Per Share | NASDAQ:ICGN | Icagen, Inc. (MM) |
| 12/08/2011 | 12:21 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ICGN | Icagen, Inc. (MM) |